Support legislation to subject American investment in adversary biotechnology to national-security review requirements.

U.S. Representatives Debbie Dingell (D-MI-06) and John Moolenaar (R-MI-02) introduced the Biotech Investment National Security Act (BINSA). This legislation would ensure American investment in adversary biotechnology is subject to the review requirements of the Comprehensive Outbound Investment National Security (COINS) Act.

Introduces a bill to add national-security review for certain biotech investments tied to adversaries.

Press Releases | Congresswoman Debbie Dingell
secondary · other · model gpt-5.4-mini